Prostate Cancer Canada Network - Toronto Man to Man

Newsletter Archive

admin — Sat, 08 May 2010 09:41:58 +0000

Newsletter Archives

December 2010
May 2010
December 2009
August 2009
May 2009
December 2008
September 2008
April 2008
December 2007
August 2007
April 2007
December 2006
October 2006
July 2006
March 2006
January 2006
September 2005
July 2005

Management of Metastatic Castration-resistant Prostate Cancer

jroth — Fri, 03 Feb 2012 17:24:55 +0000

Management of Metastatic Castration-resistant Prostate Cancer
Abstract

The management of men with metastatic castration-resistant prostate cancer (CRPC) has taken several leaps forwards in the last two years, with the demonstration of improved overall survival with three novel agents (sipuleucel-T, cabazitaxel and abiraterone acetate) and a significant delay in skeletal-related events observed with denosumab.
…

Click here for more.

Dutasteride in localised prostate cancer management

jroth — Thu, 02 Feb 2012 01:01:24 +0000

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

Interpretation

Dutasteride could provide a beneficial adjunct to active surveillance for men with low-risk prostate cancer.

Click here for full article.

Extending Lives of Men With Prostate Cancer

jroth — Thu, 02 Feb 2012 00:38:47 +0000

Advanced prostate cancer patients live longer with MDV3100

Reviewed By: Joseph V. Madia, MD [www.dailyrx.com]
By: Laurie Stoneham [www.dailyrx.com]
Published: Jan 31, 2012 04:17 pm

Click here to see article.

Brachytherapy for High-Risk Patients

jroth — Fri, 27 Jan 2012 15:48:46 +0000

ScienceDaily (Jan. 25, 2012) — Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise.

Diagnosis on a Microchip

jroth — Fri, 27 Jan 2012 15:40:17 +0000

Toronto’s medical community is buzzing about an invention that could change the way health professionals screen for infectious disease and cancer.
“We’ve been working on this, really, for about a decade,” said Dr. Shana Kelley, a scientist at the University of Toronto.
Kelley spoke as she held a small black device her hand, shaped like a smartphone but bulkier, with a microchip inside that Kelley says can determine in 15 minutes if you have cancer or an infectious disease.

Rediscovering Sex After Prostate Cancer

jroth — Sun, 22 Jan 2012 19:08:36 +0000

Most discussions about erectile dysfunction and sex after prostate cancer treatment talk about things from drugs (Viagra, Cialis, Levitra) to penile implants. For another approach, watch this video from PCCN-Calgary.

Focal Therapy

admin — Tue, 17 Jan 2012 18:30:13 +0000

Dr. Uri Lindner, a medical associate of Dr. Trachtenberg at PMH, will be our guest speaker at our 25 July 2012 Awareness Night at Toronto Botanical Gardens. His topic will be Focal Therapy. Click here for more information on Focal Therapy.

Awareness, The PCCN Toronto and Side by Side Prostate Cancer Support Newsletter

admin — Fri, 30 Dec 2011 23:45:06 +0000

Awareness, The PCCN Toronto and Side by Side Prostate Cancer Support December 2011 Newsletter (pdf)

Dr. Myers talks about active surveillance versus watchful waiting for prostate cancer

jroth — Tue, 20 Dec 2011 16:04:34 +0000

Dr. Myers compares active surveillance and watchful waiting for prostate cancer in this 6:51 video. Click here to view.